Nitric oxide inhibits aggrecan degradation in explant cultures of equine articular cartilage.
Authors: Bird J L, May S, Bayliss M T
Journal: Equine veterinary journal
Summary
# Editorial Summary: Nitric Oxide and Equine Cartilage Degradation Understanding how inflammatory mediators regulate cartilage breakdown is critical to managing osteoarthritis in horses, yet the role of nitric oxide (NO) in this process remains complex and sometimes contradictory. Bird, May and Bayliss investigated NO's dual function in equine articular cartilage using explant culture models, exposing tissue to inflammatory triggers (interleukin-1 and retinoic acid) alongside NO donors and enzyme inhibitors to track changes in aggrecan—the cartilage proteoglycan responsible for load-bearing capacity. Their key finding revealed an unexpected protective mechanism: whilst NO mediated the catabolic effects of IL-1 on proteoglycan *synthesis*, it simultaneously *inhibited* proteoglycan *degradation* and specifically suppressed aggrecanase cleavage of aggrecan into G1 fragments that appear in joint fluid. This paradox has significant implications for joint therapy; any anti-inflammatory strategy targeting NO must account for its protective role in preventing cartilage matrix breakdown, as blunt inhibition could accelerate rather than slow degenerative changes. For equine practitioners, the findings suggest that maintaining NO bioavailability during inflammatory episodes may help preserve cartilage integrity, offering a rationale for interventions that support endogenous NO production rather than suppress it entirely.
Read the full abstract on PubMed
Practical Takeaways
- •NO has dual roles in joint tissue turnover (both catabolic and anticatabolic), so pharmacological interventions targeting NO must consider both effects to avoid unintended consequences
- •Blocking NO production may increase cartilage proteoglycan degradation and worsen osteoarthritis progression, suggesting NO-preserving therapies may be beneficial
- •Understanding NO's protective role against aggrecanase-mediated cartilage breakdown could inform development of joint disease management strategies in horses
Key Findings
- •Nitric oxide fully mediated the suppressive effect of IL-1 on proteoglycan synthesis in equine cartilage explants
- •Exogenous NO decreased the appearance of aggrecanase cleavage epitopes and antagonized proteoglycan degradation irrespective of degradation stimulus
- •NO exerts an anticatabolic role in cartilage proteoglycan degradation, suggesting regulation of aggrecanase activity as the mechanism